Blog
IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment…
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…
Read MoreWhat were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…
View ReportWhat were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…
Read MoreThis podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and…
View ReportExplore the IPC psoriasis severity reclassification and understand new criteria for identifying patients who may…
View ReportThe 2025 IPC Think Tank Congress Report highlights psoriasis as a systemic immunometabolic disease, linking obesity,…
Read MoreThe International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
View ReportIPC President Dr. Bruce Strober outlines the wide differential diagnosis of scaly red skin conditions beyond…
Watch VideoIn this Take Ten with IPC video, IPC President Dr. Bruce Strober discusses IPC’s latest publication, which…
Watch VideoEarly and effective treatment in psoriasis mitigates cumulative chronic disease burden and may prevent psoriatic…
View ReportThe 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
Read MoreAt the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and…
Read MoreKey takeaways from the 2025 EADV Congress in Paris, including the IPC Symposium on psoriasis, Free Communication…
View ReportExperts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…
Read MoreIPC’s 2025 SID Congress Report highlights the most impactful psoriasis sessions, covering novel cell-biology…
Read MoreThe 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…
Read MoreWelcome the newest leadership to the IPC Board of Directors! Meet incoming IPC President Bruce Strober, Vice…
Read MoreThe Psoriasis: From Gene to Clinic Congress Report highlights breakthroughs in genetics, clinical care, and treatment…
Read MoreIPC MASTERCLASS | CHICAGO, ILLINOIS, UNITED STATES Program chairs: Melinda Gooderham, Canada and Bruce Strober,…
INTERNATIONAL FEDERATION OF PSORIASIS ASSOCIATION CONFERENCE (IFPA) | STOCKHOLM, SWEDEN Friday, June 28 17:45 - 18:45…
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.